Flexor Hallucis Longus Tendon Transfer VS Gastrocnemius Augmented Flexor Hallucis Longus Tendon Transfer in Management of Achilles Tendon Defect

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12+
SponsorAssiut University

About this trial

This study aims to compare the functional outcome of Isolated Flexor hallucis longus tendon transfer and Gastrocnemius Augmented Flexor hallucis longus tendon transfer in repair of Achilles tendon defects. Also, compare the two procedures regarding complication rate, time to restore the function, and the need for secondary procedures.

Eligibility criteria

Qualifiers

Age range: Adolescents and adults with skeletally mature feet (above 12 y in females and 14 years in males).

Achilles Tendon defects more than 4 cm resulted from acute or chronic rupture, post-debridement defects in case of neglected insertional tendinopathy, spontaneous ruptures due to tendinosis or after tumor resection.

Disqualifiers

General medical contraindications to surgical interventions

Calcaneal Fracture, subtalar fusion

infection or previous surgery in the ipsilateral hindfoot or ankle

Systemic disease including seronegative inflammatory diseases, spondyloarthropathies or sarcoidosis.

Trial design

Treatments tested in this trial

  • Flexor hallucis longus tendon transfer
  • Gastrocnemius augmented Flexor hallucis longus tendon transfer

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators